Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome
- PMID: 30210801
- PMCID: PMC6123423
- DOI: 10.1038/s41439-018-0026-6
Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome
Abstract
Approximately 80% of cases of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) harbor a heteroplasmic m.3243A>G transition in the tRNALeu (UUR) (MTTL1) gene. We report a MELAS case with a rare heteroplasmic m.3243A>T mutation found by direct sequencing of MTTL1. This mutation has been previously reported in 5 cases, of which 2 cases had the MELAS phenotype. Our case also strengthens the hypothesis that the m.3243A>T mutation can cause the MELAS phenotype.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):3022-3037. doi: 10.1016/j.bbadis.2018.06.014. Epub 2018 Jun 19. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29928977
-
Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation.J Neurol. 2013 Apr;260(4):1071-80. doi: 10.1007/s00415-012-6763-4. Epub 2012 Nov 30. J Neurol. 2013. PMID: 23196335
-
Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes.Mol Diagn Ther. 2006;10(6):381-9. doi: 10.1007/BF03256215. Mol Diagn Ther. 2006. PMID: 17154655
-
Molecular pathology of MELAS and L-arginine effects.Biochim Biophys Acta. 2012 May;1820(5):608-14. doi: 10.1016/j.bbagen.2011.09.005. Epub 2011 Sep 14. Biochim Biophys Acta. 2012. PMID: 21944974 Review.
-
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.Mol Genet Metab. 2015 Sep-Oct;116(1-2):4-12. doi: 10.1016/j.ymgme.2015.06.004. Epub 2015 Jun 15. Mol Genet Metab. 2015. PMID: 26095523 Review.
Cited by
-
Investigation of Mitochondrial Related Variants in a Cerebral Small Vessel Disease Cohort.Mol Neurobiol. 2022 Sep;59(9):5366-5378. doi: 10.1007/s12035-022-02914-3. Epub 2022 Jun 14. Mol Neurobiol. 2022. PMID: 35699875 Free PMC article.
-
Severe clinical manifestation of mitochondrial disease due to the m.3243A>T variant: a case report of early-onset, multi-organ involvement and premature death.J Rare Dis (Berlin). 2025;4(1):47. doi: 10.1007/s44162-025-00110-0. Epub 2025 Aug 8. J Rare Dis (Berlin). 2025. PMID: 40787093 Free PMC article.
-
Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.Antioxidants (Basel). 2021 Dec 2;10(12):1935. doi: 10.3390/antiox10121935. Antioxidants (Basel). 2021. PMID: 34943038 Free PMC article. Review.
-
Mitochondrial dysfunction in epilepsy: mechanistic insights and clinical strategies.Mol Biol Rep. 2025 May 20;52(1):470. doi: 10.1007/s11033-025-10577-1. Mol Biol Rep. 2025. PMID: 40392243 Review.
-
Traumatic Brain Injury Triggers Neurodegeneration in a Mildly Symptomatic MELAS Patient: Implications on the Detrimental Role of Damaged Mitochondria in Determining Head Trauma Sequalae in the General Population.Metabolites. 2022 Dec 28;13(1):46. doi: 10.3390/metabo13010046. Metabolites. 2022. PMID: 36676971 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources